4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-026451
CHAIRMAN & CEO sold 89,561 shares at $23.00 ($2,059,903)
- CHAIRMAN & CEO acquired 89,561 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2024-11-06 | Option exercise 10b5-1 | +89,561 | $1.59 | $142,402 | 169,112 | D |
| Patel Sanj K CHAIRMAN & CEO | 2024-11-06 | Sale 10b5-1 | −89,561 | $23.00 | $2,059,903 | 79,551 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2024-11-06 | Option exercise · Share Option 10b5-1 | −89,561 | 10,025 | D | ||
| Open-market sales · 89,561 sh · avg $23.00 · $2,059,903 | |||||||
Loading xslF345X05/form4-11082024_091109.xml…